Urine Proteomics in Schistosoma haematobium-induced Bladder Cancer
Article Sidebar
Main Article Content
Abstract
Schistosomiasis, or Bilharziasis, is a neglected tropical disease caused by Schistosoma parasites, which significantly impacts public health, particularly in Africa. Schistosoma haematobium, the primary species responsible for urogenital schistosomiasis (UGS), is associated with severe chronic conditions, including squamous cell carcinoma (SCC) of the bladder. This review explores the pathogenesis of UGS and its link to bladder cancer, highlighting the molecular mechanisms involved. The chronic inflammation caused by S. haematobium eggs leads to tissue damage, fibrosis, and granuloma formation, creating a pre-cancerous environment. Notably, the role of the p53 pathway in UGS-associated bladder cancer is emphasized, with mutations in the TP53 gene and overexpression of p53 contributing to genetic instability and malignant transformation. Additionally, the review discusses the presence of oestrogen-like metabolites in the urine of UGS patients, which are suspected to be involved in carcinogenesis through an oestrogen-DNA adduct-mediated pathway. Mass spectrometric analysis of urine samples from UGS patients revealed specific metabolites, including 8-oxodG, a marker of oxidative DNA damage, which could serve as potential biomarkers for early detection and progression of bladder cancer. The urine proteome profiling also identified distinct molecular pathways activated in UGS-related bladder cancer, including Th2-type immune responses, oxidative stress, and inflammation. These findings underscore the need for further research into the host-parasite interactions and the development of diagnostic biomarkers for schistosome-induced carcinogenesis. Understanding these mechanisms could enhance treatment strategies and improve prevention efforts for UGS-related bladder cancer, particularly in endemic regions where the disease burden remains high.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors hold the copyright of all published articles except otherwise stated.
References
Adell, T., & Riutort, M. (2021). Phylum Platyhelminthes. In Invertebrate Zoology (pp. 219-230). CRC Press.
Ali, Q., & Malik, A. (2024). Genetic response of growth phases for abiotic environmental stress tolerance in cereal crop plants. Genetika, 53(1), 419-456.
https://doi.org/10.2298/GENSR2101419A
Archer, J., O'Halloran, L., Al-Shehri, H., Summers, S., Bhattacharyya, T., Kabaterine, N. B., Atuhaire, A., Adriko, M., Arianaitwe, M., Stewart, M., LaCourse, E. J., Webster, B. L., Bustinduy, A. L., & Stothard, J. R. (2020). Intestinal Schistosomiasis and Giardiasis Co-Infection in Sub-Saharan Africa: Can a One Health Approach Improve Control of Each Waterborne Parasite Simultaneously? Tropical Medicine and Infectious Disease, 5(3), 137.
https://doi.org/10.3390/tropicalmed5030137
Bernardo, C., Cunha, M. C., Santos, J. H., da Costa, J. M. C., Brindley, P. J., Lopes, C., Amado, F., Ferreira, R., Vitorino, R., & Santos, L. L. (2016). Insight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics. Tumor Biology, 37(8), 11279-11287. https://doi.org/10.1007/s13277-016-4997-y
Bernardo, C., Santos, J., Costa, C., Tavares, A., Amaro, T., Marques, I., Gouveia, M. J., Félix, V., Afreixo, V., Brindley, P. J., Costa, J. M., Amado, F., Helguero, L., & Santos, L. L. (2020). Estrogen receptors in urogenital schistosomiasis and bladder cancer: Estrogen receptor alpha-mediated cell proliferation. Urologic Oncology: Seminars and Original Investigations, 38(9), 738.e23-738.e35. https://doi.org/10.1016/j.urolonc.2020.04.022
Bilharz, T. (1853). Fernere mittheilungen über Distomun haematobium. Zeitschrift fur Wissenschaftliche Zoologie, 4, 454-456.
Fabiana C., Michel, F., Olivier C., Hussa A., Comperat, E., & Véronique P. (2022). Bladder carcinomas in patients with neurogenic bladder and urinary schistosomiasis: are they the same tumors? World Journal of Urology, 40(8), 1949-1959.
https://doi.org/10.1007/s00345-022-03941-4
Cobbold, T. S. (1859). XXVII. On some new forms of Entozoa. Transactions of the Linnean Society of London, 22(4), 363-366. https://doi.org/10.1111/j.1096-3642.1856.tb00105.x
Crellen, T., Walker, M., Lamberton, P. H., Kabatereine, N. B., Tukahebwa, E. M., Cotton, J. A., & Webster, J. P. (2016). Reduced efficacy of praziquantel against Schistosoma mansoni is associated with multiple rounds of mass drug administration. Clinical Infectious Diseases, 63(9), 1151-1159. https://doi.org/10.1093/cid/ciw506
Da Costa, J. M. C., Gouveia, M. J., Rinaldi, G., Brindley, P. J., Santos, J., & Santos, L. L. (2021). Control strategies for carcinogenic-associated helminthiases: an integrated overview. Frontiers in Cellular and Infection Microbiology, 11, 626672.
https://doi.org/10.3389/fcimb.2021.626672
Das, S., Kundu, M., Jena, B. C., & Mandal, M. (2020). Causes of cancer: physical, chemical, biological carcinogens, and viruses. Biomaterials for 3D Tumour Modeling, 607-641. https://doi.org/10.1016/B978-0-12-818128-7.00025-3
Gouveia, M. J., Santos, J., Brindley, P. J., Rinaldi, G., Lopes, C., Santos, L. L., ... & Vale, N. (2015). Oestrogen-like metabolites and DNA adducts in urogenital schistosomiasis-associated bladder cancer. Cancer Letters, 359(2), 226-232.
https://doi.org/10.1016/j.canlet.2015.01.018
Hambrook, J. R., & Hanington, P. C. (2021). Immune evasion strategies of schistosomes. Frontiers in Immunology, 11, 624178. https://doi.org/10.3389/fimmu.2020.624178
Harley, J. (1864). On the endemic haematuria of the Cape of Good Hope. Medico-Chirurgical Transactions, 47, 55. https://doi.org/10.1177/095952876404700110
Hasan, A., Mohammed, Y., Basiony, M., Hanbazazh, M., Samman, A., Abdelaleem, M. F., ... & Mandour, E. (2023). Clinico-pathological features and immunohistochemical comparison of p16, p53, and Ki-67 expression in muscle-invasive and non-muscle-invasive conventional urothelial bladder carcinoma. Clinics and Practice, 13(4), 806-819.
https://doi.org/10.3390/clinpract13040073
Ishida, K., & Hsieh, M. H. (2018). Understanding urogenital schistosomiasis-related bladder cancer: an update. Frontiers in medicine, 5, 223. https://doi.org/10.3389/fmed.2018.00223
Kaseb, H., & Aeddula, N. (2022). Bladder Cancer. StatPearls. Available at: https://www.statpearls.com/point-of-care/18354
Katz, N. (2008). The discovery of Schistosomiasis mansoni in Brazil. Acta tropica, 108(2-3), 69-71. https://doi.org/10.1016/j.actatropica.2008.05.002
Khatri, V., Chauhan, N., & Kalyanasundaram, R. (2020). Parasite cystatin: an immunomodulatory molecule with therapeutic activity against immune-mediated disorders. Pathogens, 9(6), 431. https://doi.org/10.3390/pathogens9060431
Khizar, S., Mirza, Z. I., Ahmed, H., Murtaza, B., Yasrab, M., & Shahzad, K. (2022). Efficacy of voided urine cytology compared to cystoscopic findings in the detection of bladder cancer-A Pakistani perspective. Pakistan Armed Forces Medical Journal, 72(4), 1364-68. https://doi.org/10.51253/pafmj.v72i4.4248
Lo, N. C., Bezerra, F. S. M., Colley, D. G., Fleming, F. M., Homeida, M., Kabatereine, N., ... & Garba, A. (2022). Review of 2022 WHO guidelines on the control and elimination of schistosomiasis. The Lancet Infectious Diseases, 22(11), e327-e335.
https://doi.org/10.1016/S1473-3099(22)00221-3
Lu, L., Bu, L., Zhang, S. M., Buddenborg, S. K., & Loker, E. S. (2022). An overview of transcriptional responses of schistosome-susceptible (M line) or-resistant (BS-90) Biomphalaria glabrata exposed or not to Schistosoma mansoni infection. Frontiers in Immunology, 12, 805882.https://doi.org/10.3389/fimmu.2021.805882
Machado-Silva, J. R., Pelajo-Machado, M., Lenzi, H. L., & Gomes, D. C. (1998). Morphological study of adult male worms of Schistosoma mansoni Sambon, 1907 by confocal laser scanning microscopy. Memórias do Instituto Oswaldo Cruz, 93, 303-307.
https://doi.org/10.1590/S0074-02761998000700060
Macklin, A., Khan, S., & Kislinger, T. (2020). Recent advances in mass spectrometry-based clinical proteomics: applications to cancer research. Clinical proteomics, 17(1), 17. https://doi.org/10.1186/s12014-020-09283-w
Madureira, A. C. (2022). Programmed Cell Death-Ligand-1 expression in Bladder Schistosomal Squamous Cell Carcinoma-There's room for Immune Checkpoint Blockage?. Frontiers in Immunology, 13, 955000. https://doi.org/10.3389/fimmu.2022.955000
Manson, P. (1903). Tropical diseases: a manual, new and rev. London: Cassell.
Masamba, P., & Kappo, A. P. (2021). Immunological and biochemical interplay between cytokines, oxidative stress and schistosomiasis. International Journal of molecular Sciences, 22(13), 7216. https://doi.org/10.3390/ijms22137216
Mohebalizadeh, M., & Rezaei, N. (2023). Biomarkers for Monitoring the Immunotherapy Response to Cancer. In Handbook of Cancer and Immunology (pp. 1-37). Cham: Springer International Publishing. https://doi.org/10.1007/978-3-030-80962-1_131-1
Moulis, J. M. (2020). Cellular dynamics of transition metal exchange on proteins: a challenge but a bonanza for coordination chemistry. Biomolecules, 10(11), 1584.
https://doi.org/10.3390/biom10111584
Murray, D., & Mirzayans, R. (2020). Cellular responses to platinum-based anticancer drugs and UVC: Role of p53 and implications for cancer therapy. International Journal of Molecular Sciences, 21(16), 5766. https://doi.org/10.3390/ijms21165766
Nacif-Pimenta, R., da Silva Orfanó, A., Mosley, I. A., Karinshak, S. E., Ishida, K., Mann, V. H., ... & Rinaldi, G. (2019). Differential responses of epithelial cells from urinary and biliary tract to eggs of Schistosoma haematobium and S. mansoni. Scientific Reports, 9(1), 10731. https://doi.org/10.1038/s41598-019-46917-y
Osakunor, D. N., Ishida, K., Lamanna, O. K., Rossi, M., Dwomoh, L., & Hsieh, M. H. (2022). Host tissue proteomics reveals insights into the molecular basis of Schistosoma haematobium-induced bladder pathology. PLoS Neglected Tropical Diseases, 16(2), e0010176. https://doi.org/10.1371/journal.pntd.0010176
Park, S.-K., Friedrich, L., Yahya, N. A., Rohr, C. M., Chulkov, E. G., Maillard, D., Rippmann, F., Spangenberg, T., & Marchant, J. S. (2021). Mechanism of praziquantel action at a parasitic flatworm ion channel. Science Translational Medicine, 13(625).
https://doi.org/10.1126/scitranslmed.abj5832
Parsegian, K., Trivedi, R., & Ioannidou, E. (2021). Renal Diseases. Burket's Oral Medicine, 579-626. https://doi.org/10.1002/9781119597797.ch16
Roy, P., Kandel, R., Sawant, N., & Singh, K. P. (2024). Oestrogen-induced reactive oxygen species, through epigenetic reprogramming, causes increased growth in breast cancer cells. Molecular and Cellular Endocrinology, 579, 112092.
https://doi.org/10.1016/j.mce.2023.112092
Santos, L. L., Santos, J., Gouveia, M. J., Bernardo, C., Lopes, C., Rinaldi, G., ... & Costa, J. M. C. D. (2021). Urogenital schistosomiasis-history, pathogenesis, and bladder cancer. Journal of Clinical Medicine, 10(2), 205. https://doi.org/10.3390/jcm10020205
Sprague, D. J., Kaethner, M., Park, S. K., Rohr, C. M., Harris, J. L., Maillard, D., ... & Marchant, J. S. (2023). The anthelmintic activity of praziquantel analogs correlates with structure-activity relationships at TRPMPZQ Orthologs. ACS Medicinal Chemistry Letters, 14(11), 1537-1543. https://doi.org/10.1021/acsmedchemlett.3c00350
Sturt, A. S., Webb, E. L., Francis, S. C., Hayes, R. J., & Bustinduy, A. L. (2020). Beyond the barrier: female genital schistosomiasis as a potential risk factor for HIV-1 acquisition. Acta Tropica, 209, 105524.https://doi.org/10.1016/j.actatropica.2020.105524
Turner, M. C., Cogliano, V., Guyton, K., Madia, F., Straif, K., Ward, E. M., & Schubauer-Berigan, M. K. (2023). Research recommendations for selected IARC-classified agents: impact and lessons learned. Environmental Health Perspectives, 131(10), 105001.
https://doi.org/10.1289/EHP12547
Volesky-Avellaneda, K. D., Morais, S., Walter, S. D., O'Brien, T. R., Hildesheim, A., Engels, E. A., ... & Franco, E. L. (2023). Cancers attributable to infections in the US in 2017: A meta-analysis. JAMA Oncology, 9(12), 1678-1687.
https://doi.org/10.1001/jamaoncol.2023.4273
Wang, W., Bergquist, R., King, C. H., & Yang, K. (2021). Elimination of schistosomiasis in China: Current status and prospects. PLOS Neglected Tropical Diseases, 15(8), e0009578.
https://doi.org/10.1371/journal.pntd.0009578
Webster, B. L., Diaw, O. T., Seye, M. M., Webster, J. P., & Rollinson, D. (2013). Introgressive hybridization of Schistosoma haematobium group species in Senegal: species barrier break down between ruminant and human schistosomes. PLoS Neglected Tropical Diseases, 7(4), e2110. https://doi.org/10.1371/journal.pntd.0002110
Zaghloul, M. S., Zaghloul, T. M., Bishr, M. K., & Baumann, B. C. (2020). Urinary schistosomiasis and the associated bladder cancer: update. Journal of the Egyptian National Cancer Institute, 32, 1-10. https://doi.org/10.1186/s43046-020-00055-z